Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA (pregabalin) in Primary Generalized Tonic-Clonic Seizures Read more
AveXis Announces Innovative Zolgensma Gene Therapy Access Programs for US Payers and Families Read more
FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease Read more
Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA (pregabalin) in Primary Generalized Tonic-Clonic Seizures Read more
AveXis receives FDA approval for Zolgensma, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA) Read more
GSK announces approval of Shingrix in China for prevention of shingles in adults aged 50 and over Read more
ProBioGen and Abcuro signed GlymaxX-Improved Cell Line Development and GMP Production Agreement Read more
Santhera Enters into License Agreement with Chiesi Group for Raxone in LHON Valued at up to CHF 105 Million Read more